-
Dark Genome Therapeutics Market Size To Reach USD 11,945.7 Million In 2032
19 Jun 2025 13:40 GMT
… Therapeutics
oHERVolution Therapeutics
oHAYA Therapeutics
oNucleome Therapeutics
oEnhanc3D Genomics Ltd
oNextRNA Therapeutics
oAmaroq Therapeutics … candidate HTX-001 in heart failure, as well as … Vaccines
oDark Genome Therapeutics
.Target Type Outlook …
-
Breakthrough: Researchers identify cause of heart failure in obese individuals
18 Jun 2025 14:17 GMT
… potential for cross-disciplinary therapies.
Obesity has been linked … this matters for humans Heart failure linked to obesity — … trials testing AB42-blocking therapies in heart patients could … learn more about obesity, heart failure and the obesity paradox …
-
Medications for Heart Failure Market Report 2025 – Strategic Insights for Expansion, Growth & Competitive Edge
18 Jun 2025 11:03 GMT
… , a strong pipeline of combination therapies and fixed-dose formulations, updated … the development and enhancement of therapies to better manage symptoms and … The Medications For Heart Failure Market?
The medications for heart failure market can be …
-
HELP Therapeutics and China Resources Sanjiu partner to co─develop and commercialize HiCM─188 for advanced heart failure
18 Jun 2025 11:11 GMT
… commercialize the investigational cell therapy HiCM-188.
Heart failure remains a major … first iPSC-derived regenerative therapy for heart failure to receive IND clearance … noted that HELP Therapeutics'; focus on heart failure addresses a critical clinical …
-
Novel cardiology therapy for cats is launched
18 Jun 2025 22:21 GMT
A new therapy for managing ventricular hypertrophy … focus remained on the novel therapy.1
“It is indeed … , which can lead to heart failure and other complications, including … disease develop symptoms of congestive heart failure, many others remain subclinical …
-
New Era in Heart Health: ATTR-CM Therapies Revolutionize Treatment for Transthyretin Amyloid Cardiomyopathy | CI Insight
18 Jun 2025 17:13 GMT
… -cardiomyopathy-genetic-disease-modifying-therapies
Understanding the Disease: When … diastolic dysfunction, arrhythmias, and heart failure.
Two main types of ATTR … -cardiomyopathy-genetic-disease-modifying-therapies
Looking Ahead: Strategic Takeaways …
-
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
18 Jun 2025 13:30 GMT
… diastolic dysfunction and progression to heart failure with preserved ejection fraction (“ … heart failure. The data I will review at CSI explore how AVIM therapy … heart failure;
The growing body of clinical and mechanistic evidence demonstrating AVIM therapy …
-
Changes in Aortic Valve Signal Heart Failure Progression
17 Jun 2025 13:00 GMT
TOPLINE:
In patients with chronic heart failure (HF), the presence of aortic … clinical follow-up, more intensive therapy, and stricter risk factor control …
-
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
18 Jun 2025 11:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a … or worse high blood pressure
heart failure
life-threatening skin reactions
liver … Medication Guide. About Axsome Therapeutics Axsome Therapeutics is a biopharmaceutical company leading …
-
Iron Deficiency Anemia Therapy Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
18 Jun 2025 08:42 GMT
… Hydroxide; by Therapy Type - Parenteral Iron Therapy, Oral Iron Therapy, Red … Cell Transfusion, Other Therapy Types; by Therapy Areas - Inflammatory Bowel … Diseases, Obstetrics and Gynecology, Congestive Heart Failure, Oncology; by Distribution Channel - …